Dr Ashwin Venkataraman is an Alzheimer's Society Clinical Research Fellow at the UKDRI at Imperial College London.
He is currently trying to understand early changes in Alzheimer's disease by looking at the mitochondria, synapses and amyloid.
He is working with Professor Paul Matthews and uses brain Positron Emission Tomography (PET) and Magnetic Resonance (MRI) imaging.
Prior to this he was an Alzheimer's Research UK Clinical Fellow at the Neuropsychopharmacology Unit at Imperial College London working on how alcohol adds to amyloid deposition, and investigating a novel Imidazoline-2 receptor radioligand for Alzheimer's disease.
He is a Member of the Royal College of Psychiatrists. Before this he was an NIHR Academic Clinical Fellow, Academic Foundation Programme Doctor, and graduated from University College London Medical School.
et al., Evaluation of mitochondrial and synaptic function in Alzheimer’s disease (AD): a [18F]BCPP-EF, [11C]SA4503 and [11C]UCB-J PET study, Journal of Cerebral Blood Flow and Metabolism, Vol:39, ISSN:1559-7016, Pages:121-122
et al., 2018, First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site, Ejnmmi Research, Vol:8, ISSN:2191-219X
et al., 2016, Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?, Alcohol and Alcoholism, Vol:52, ISSN:1464-3502, Pages:151-158
Venkataraman A, Perry R, Malhotra P, Young Onset Dementia